We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.12B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+144%
3 Year Est. Return
+348.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$515M
Cap. Flow
+$653M
Cap. Flow %
10.66%
Top 10 Hldgs %
53.58%
Holding
69
New
14
Increased
25
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$169M
2
NUVL
Nuvalent
NUVL
+$140M
3
OCUL icon
Ocular Therapeutix
OCUL
+$111M
4
GMAB icon
Genmab
GMAB
+$110M
5
VERA icon
Vera Therapeutics
VERA
+$55.4M

Top Sells

Rank Stock Value
1
DVAX
Dynavax Technologies
DVAX
+$242M
2
CYTK icon
Cytokinetics
CYTK
+$125M
3
APLS
Apellis Pharmaceuticals
APLS
+$69.3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$67.1M
5
MAZE
Maze Therapeutics
MAZE
+$33.9M

Sector Composition

Rank Sector Weight
1 Healthcare 79.14%

No holdings matched the selected filter criteria.

1 2 3

Similar funds

AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Deep Track Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Deep Track Capital held 69 positions worth $6.12B, up 9.2% from $5.61B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deep Track Capital deployed $653M of net new capital in Q1 2026, opening 14 new positions and adding to 25 existing holdings. Its largest new stake was Alumis Inc: 6,772,595 shares worth $149M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 78% a quarter earlier.

On the sell side, the largest reduction was Cytokinetics, an estimated $125M trimmed.

  • Deep Track Capital's largest Q1 2026 buy was Alumis Inc: 6,772,595 shares worth $149M.
  • Deep Track Capital added most to Ocular Therapeutix in Q1 2026, an estimated $111M increase.
  • Deep Track Capital's biggest Q1 2026 reduction was Cytokinetics, cutting an estimated $125M.
  • Deep Track Capital fully exited Dynavax Technologies in Q1 2026, selling an estimated $242M.
  • Deep Track Capital's ten largest holdings make up 54% of its $6.12B portfolio in Q1 2026.
  • Deep Track Capital opened 14 new positions and closed 6 in Q1 2026.
  • Deep Track Capital's portfolio value rose 9.2% quarter-over-quarter to $6.12B.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.